deltatrials
Unknown PHASE2 NCT00004375

Ultraviolet Light Therapy for Systemic Lupus Erythematosus

Sponsor: Louisiana State University Health Sciences Center in New Orleans

Conditions Systemic Lupus Erythematosus
Interventions ultraviolet A-1 light treatment
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Sep 30, 1991

A PHASE2 clinical study on Systemic Lupus Erythematosus, this trial is ongoing. The trial is conducted by Louisiana State University Health Sciences Center in New Orleans and has accumulated 5 data snapshots since 1991. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Sep 1991

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Louisiana State University Health Sciences Center in New Orleans
  • National Center for Research Resources (NCRR)
Data source: National Center for Research Resources (NCRR)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New Orleans, United States